An Open-Label Study of the Safety and Efficacy of Zipsor (Diclofenac Potassium) Liquid Filled Capsules in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute Pain
Phase of Trial: Phase IV
Latest Information Update: 15 Aug 2018
Price : $35 *
At a glance
- Drugs Diclofenac (Primary)
- Indications Acute pain
- Focus Adverse reactions
- Sponsors Assertio Therapeutics; Depomed
- 15 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 May 2014 Planned End Date changed from 1 Oct 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.